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p27Kip1 knockout mice are protected from diabetic nephropa-
thy: Evidence for p27Kip1 haplotype insufficiency.
Background. High glucose up-regulates the mesangial cell
expression of p27Kip1, an inhibitor of cyclin-dependent ki-
nases/cyclin complexes. Previous in vitro studies using cultured
mesangial cells from p27Kip1−/− mice demonstrated that these
cells do not undergo high glucose-mediated cellular hypertro-
phy. Since glomerular hypertrophy is an early feature of diabetic
nephropathy and may precede the development of glomeru-
losclerosis, interference with p27Kip1 expression may attenuate
diabetic nephropathy. However, it is unclear whether deletion
of p27Kip1 protects the kidneys of diabetic nephropathy in vivo.
Methods. Type 1 diabetes mellitus was induced in p27Kip1+/+,
p27Kip1+/−, and p27Kip1−/− mice by injection of streptozotocin
(STZ). Mice were studied for 6 weeks. Animals injected with
citrate buffer only served as controls. At the end of the experi-
ments, urine was collected, albuminuria was determined with
an enzyme-linked immunosorbent assay (ELISA), and blood
glucose concentrations were measured. Kidneys were
perfusion-fixed for quantitative morphologic analysis with
glutaraldehyde and for immunohistochemical studies with
formaldehyde. Glomerular cell number and volume were
analyzed. Glomerulosclerosis, tubulointerstitial, and vascular
damage indices were semiquantitatively assessed according to
standard methodology. Quantitative glomerular parameters
(cell numbers and volumes of endothelial, mesangial, and
epithelial cells) were measured on semithin sections. Expres-
sion of transforming growth factor-b1 (TGF-b1), laminin, and
collagen type IV were determined by immunohistochemical
staining.
Results. In contrast to animals only injected with citrate
buffer, mice that received STZ developed hyperglycemia. There
was no significant difference in the degree of hyperglycemia
among p27Kip1+/+, p27Kip1+/−, and p27Kip1−/− mice. Diabetic
p27Kip1+/+, but not control p27Kip1+/+ animals, developed al-
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buminuria. Albuminuria was significantly reduced in diabetic
p27Kip1+/− and more profoundly in p27Kip1−/− animals. Dia-
betic p27Kip1+/+ mice revealed a significant increase in mean
glomerular volume at 6 weeks. The volumes of mesangial
and endothelial cells and podocytes all increased, whereas
cell numbers were reduced, consistent with cell hypertrophy.
Glomerular, endothelial, mesangial and podocyte hypertrophy
were reduced in diabetic p27Kip1+/− and p27Kip1−/− animals.
Diabetic p27Kip1 +/+ animals had significantly increased
glomerulosclerosis, tubulointerstium, and vascular damage in-
dices compared to nondiabetic p27Kip1+/+ controls. Diabetic
p27Kip1−/− mice exhibited significantly less structural damage
than diabetic wild-type animals. Diabetic p27Kip1+/− animals re-
vealed intermediate glomerulosclerosis, tubulointerstium, and
vascular damage values. Immunohistological stainings demon-
strated increases in TGF-b1, collagen type IV, and laminin ex-
pression in kidneys of diabetic p27Kip1+/+ animals compared
to nondiabetic p27Kip1+/+ controls. Staining intensity for type
IV collagen and laminin, but not for TGF-b1, was significantly
lower in diabetic p27Kip1−/− mice.
Conclusion. Deletion of p27Kip1 attenuates the functional and
morphologic features of diabetic nephropathy. Although dele-
tion of p27Kip1 abolished some parameters of diabetic glomeru-
lar hypertrophy, the significant reduction of TGF-b1 expression
in the tubulointerstitium indicates that other protective mecha-
nisms could be operative. The p27Kip1 gene is haplo-insufficient
because diabetic p27Kip1 +/− mice exhibited an intermediate
degree of functional and structural renal injury. Our data shows
that p27Kip1 plays an important role in diabetic nephropathy.
Prevention, early detection and treatment of diabetic
nephropathy are major health care issues, not only be-
cause of the epidemiological increase in incidence of
patients with type 2 diabetes, but also because of the as-
sociated high cardiovascular mortality in diabetics with
impaired renal function [1, 2]. A successful intervention
would require targeting early pathophysiologic processes
before irreversible structural changes occurred [3]. One
of the earliest structural renal manifestations following
the onset of hyperglycemia is renal hypertrophy [4]. Data
derived from cell culture studies exposing mesangial cells
to various glucose concentrations as well as in vivo stud-
ies suggest a biphasic growth response. There is a very
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early and self-limited proliferation of mesangial cells with
subsequent cell cycle arrest in the G1 phase and con-
comitant hypertrophy [5]. We have reported that high
glucose-mediated G1 arrest was due to the up-regulation
of the cyclin-dependent kinase inhibitor p27Kip1 [6,
7]. This increase in p27Kip1 expression is not medi-
ated by increased gene transcription. Rather, high glu-
cose increases p27Kip1 protein stability by activating the
mitogen-activated protein (MAP) kinases, extracellular
signal-regulated protein kinase (ERK1/2), that, in turn,
directly phosphorylate p27Kip1 [8]. A functional role for
p27Kip1 in mediating mesangial hypertrophy was proven
by demonstrating that high glucose failed to induce hyper-
trophy in p27Kip1−/− mesangial cells, but not in p27Kip1−/−
mesangial cells [9]. This response could be restored by re-
constituting p27Kip1 expression [9].
Whether manipulation of p27Kip1 in vivo would influ-
ence diabetic nephropathy is, however, not totally clear.
A recent study showed that mesangial expansion and
albuminuria were milder in diabetic p27Kip1−/− mice
compared to the diabetic wild-type [10]. However,
heterozygous animals were not studied and quantita-
tive morphometric parameters were not evaluated [10].
Therefore, the present study investigates meticulously
structural and functional renal changes in streptozotocin
(STZ)-induced diabetes type 1 in p27Kip1 wild-type+/+,
heterozygous+/−, and knockout−/− mice. Our data reveal
that the development of diabetic nephropathy is attenu-
ated in p27Kip1−/− mice compared to wild-type animals
whereas heterozygous+/− mice exhibit an intermediate
phenotype.
METHODS
Animals
Heterozygous p27Kip1+/− (C57BL/6J-Cdkn1btm1Mlf )
founders were obtained from Jackson Laboratory (Bar
Harbor, ME, USA) and a colony was established at the
University of Hamburg [11]. All animal experiments were
performed according to federal, state, and local laws and
in accordance with the Institute for Laboratory Animal
Research Guide for Care and Use of Laboratory Ani-
mals. Genotypes were confirmed on DNA isolated from
tail biopsies. Homozygous p27Kip1 deletion are charac-
terized by the presence of a 0.5 kb polymerasse chain re-
action (PCR) fragment unique to the mutant transgene
using primers 5′-CCTTCTATGGCCTTCTTGACG-3′
and 5′-TGGAACCCTGTGCCATCTCTAT-3′ [11]. The
wild-type p27Kip1+/+ was characterized by the presence
of a unique 0.9 kb fragment using primers 5′-TGGAA
CCCTGTGCCATCTCTAT-3′, and 5′-GAGCAGACG
CCCAAGAAGC-3′. Mice were fed standard pellet lab-
oratory chow and received water ad libitum.
Diabetes was induced in 8- to 10-week-old mice of both
genders by three consecutively daily intraperitoneal in-
jections of STZ (200 mg/kg body weight) (Sigma-Aldrich
Chemicals, Munich, Germany) dissolved in 10 mmol/L
sodium citrate buffer (pH 5.5) [12]. Control animals
were injected only with citrate buffer. Mice that devel-
oped glucosuria received a subcutaneous insulin implant
(Linplant) (Linshin, Ontario, Canada) to prevent ke-
toacidosis. After 6 weeks of hyperglycemia, urine was
collected in metabolic cages and albumin excretion was
determined with an enzyme-linked immunosorbent assay
(ELISA). Animals were weighted before venous blood
glucose concentrations were measured with B glucose an-
alyzer (HemoCue, A¨ngelholm, Sweden).
Tissue preparation
Kidneys were retrogradely perfused with phosphate
buffer and fixed with 3% glutaraldehyde as previously
described [13]. After weighing individual kidneys, kid-
neys were sectioned in a plane perpendicular to the in-
terpolar axis, yielding slices of 1 mm width. Ten small
pieces of the each kidney were selected by area sam-
pling and embedded in Epon-Araldite (SPT Supplies,
West Chester, PA, USA). Semithin (1 lm) and ultrathin
(0.08 lm) sections were prepared and stained with methy-
line blue/basic fuchsine [13]. The remaining tissues slides
were embedded in paraffin and 4 lm sections were stained
with hematoxylin and eosin or periodic acid-Schiff (PAS)
stain. For immunohistologic studies, experiments were re-
peated and kidneys perfused with ice-cold sodium chlo-
ride and fixed in 4% buffered formaldehyde. Tissue was
embedded in paraffin and cut into 2 lm sections.
Morphologic studies
The glomerulosclerosis index was determined on PAS-
stained paraffin sections according to a previously de-
scribed scoring system (scores of 0 to 4) for each animal
as the arithmetic mean of assessing 100 glomeruli [14].
The tubulointerstitial index and vascular damage were
assessed as previously described on PAS-stained paraffin
sections at a magnification of ×100 [15, 16]. Mesangioly-
sis (i.e., dissolution of the mesangial matrix with capillary
dilation due to damage to mesangial or endothelial cells
or the mesangial matrix, respectively) is a hallmark of
glomerular damage in diabetic nephropathy. The mesan-
giolysis score was determined on PAS-stained paraffin
sections and graded in 100 systematically subsampled
glomeruli per animal using the following scoring sys-
tem: score 0, no changes of capillaries; score 1, capil-
lary dilatation <25% of capillary convolution; score 2,
capillary dilatation >25% of capillary convolution or cap-
illary aneurysm <50% of the capillary convolution; score
3, capillary aneurysm comprising 50% to 75% of the cap-
illary convolution; and score 4, capillary aneurysm com-
prising >75% of the capillary convolution.
Glomerular cell number and volume were analyzed
in semithin sections with a 100-point eyepiece for point
counting at a magnification of ×1000 (oil immersion) as
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Table 1. Basic animal data at the end of the experiment
Body Kidney Kidney weight/body Blood glucose Albuminuria
weight g weight g weight g/g × 10−3 mg/dL lg/24 hours
p27Kip1+/+ controls (3 and 4 ) 32.9 ± 3.7 0.19 ± 0.01 7.11 ± 0.13 184 ± 32 0.72 ± 0.17
p27Kip1+/+ diabetic (3 and 5 ) 24.9 ± 1.3a 0.19 ± 0.01 8.37 ± 0.68a 299 ± 30a 26.14 ± 3.31b
p27Kip1+/− controls (2 and 2 ) 32.6 ± 0.9 0.23 ± 0.01 7.83 ± 0.33 160 ± 22 0.73 ± 0.13
p27Kip1 +/− diabetic (4 and 8 ) 26.6 ± 1.2c 0.21 ± 0.02 8.12 ± 0.56 333 ± 28c 8.30 ± 1.50c
p27Kip1−/− controls (2 and 3 ) 28.5 ± 1.5 0.18 ± 0.01 7.24 ± 0.68 155 ± 45 1.14 ± 0.12
p27Kip1−/− diabetic (5 and 7 ) 29.6 ± 1.2a 0.23 ± 0.01 8.14 ± 0.49 328 ± 22d 2.87 ± 0.34d,e
Abbreviations are: , female; , male animals.
aP < 0.05 versus controls +/+; bP < 0.01 versus controls +/+; cP < 0.05 versus controls +/−; dP < 0.05 versus controls −/−; eP < 0.01 versus diabetic +/+.
previously described [16, 17]. Glomerular cell numbers
(podocytes, mesangial cells, and endothelial cells) were
calculated in at least 30 glomeruli for each animal, from
cell density per volume (NcV) and volume density of the
respective cell type (VcV) according to the formula
NcV = j/b × Nc1.5A /Vc0.5V
with j = 1 and b = 1.5 for podocytes and b = 1.4 for
mesangial and endothelial cells [13, 16]. The respective
cell volumes were calculated according to the equation
Vc = VcV × Vglom. All morphologic analyses were done
in a blinded fashion (i.e., the observer was unaware to
which group the animal belonged.
Immunohistologic investigations
Immunohistologic stainings were performed with anti-
bodies against laminin, collagen type IV, and transform-
ing growth factor-b1 (TGF-b1). Formaldehyde-fixed
tissue was used and immunohistochemical stainings were
performed exactly as previously described with appropri-
ate positive and negative controls [13].
Statistical analysis
All data are presented as the mean ± SEM. Statisti-
cal significance between different groups was first tested
with the Kruskal-Wallis test. Individual groups were sub-
sequently tested using the Wilcoxon-Mann-Whitney test.
A P value of <0.05 was considered significant.
RESULTS
Basic animal data
Basic animal data are shown in Table 1, 6 weeks after
induction of type 1 diabetes. Body weight was significant
reduced in diabetic p27Kip1+/+ and p27Kip1+/− animals
compared to nondiabetic controls. In contrast, p27Kip1−/−
diabetic mice exhibited a similar body weight as nondia-
betic p27Kip1−/− controls (Table 1). This was not caused by
a better control of hyperglycemia because blood glucose
concentrations were not significantly different among
diabetic p27Kip1+/+, p27Kip1+/−, and p27Kip1−/− animals
(Table 1). Total weights of perfusion fixed kidneys
were not different (Table 1). However, the kidney to
body weight ratio was significantly increased in diabetic
p27Kip1+/+ animals compared to nondiabetic controls sug-
gesting renal hypertrophy (Table 1). Although the kidney
to body weight ratio was increased in diabetic p27Kip1−/−
mice compared to control p27Kip1−/− animals, this change
was statistically not significant (Table 1).
Albuminuria
Albuminuria was significantly enhanced in p27Kip1+/+
diabetic animals compared with controls (Table 1). The
increase in albuminuria was less in diabetic heterozy-
gous p27Kip1+/− animals and substantially less in diabetic
p27Kip1−/− mice compared with their respective nondi-
abetic controls (Table 1). Albuminuria was significant
lower in diabetic p27Kip1−/− animals compared with di-
abetic p27Kip1+/+ wild-types (Table 1).
Morphologic findings
Morphometric measurements revealed no significant
differences in the cortical volume between control and
diabetic p27Kip1+/+, nor between control and diabetic
p27Kip1+/− animals. However, cortex volume was sig-
nificantly increased in diabetic p27Kip1−/− mice com-
pared with nondiabetic p27Kip1−/− controls (Table 2).
Mean glomerular volume measured by morphometry
was significantly increased in diabetic p27Kip1+/+ animals
compared to the corresponding nondiabetic genotypes
(Table 2). However, mean glomerular volume did not in-
crease in diabetic p27Kip1+/− and p27Kip1–/− mice. These
results indicate that the p27Kip1 genotype is a critical de-
terminant of glomerular hypertrophy (Table 2).
Glomerulosclerosis index, tubulointerstitial index, and
vascular damage index were all significantly higher
in diabetic p27Kip1+/+ mice compared to nondiabetic
p27Kip1+/+ controls (Table 2). Examples of low magnifi-
cation photographs are provided in Figure 1. In contrast,
diabetic p27Kip1−/− mice exhibited no increase in
glomerulosclerosis index, tubulointerstitial index, and
vascular damage index compared to nondiabetic
p27Kip1−/− animals (Table 2) (Fig. 1). Compared with di-
abetic p27Kip1+/+ mice, glomerulosclerosis index, tubu-
lointerstititial index, and vascular damage index were
significantly lower in diabetic p27Kip1−/− animals
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Table 2. Glomerular geometric parameters, renal damage indices, and mesangiolysis
Cortical Mean glomerular Glomerulosclerosis Tubulointerstitial Vascular
volume volume ×103 lm3 index index damage index Mesangiolysis
p27Kip1+/+ controls (3 and 4 ) 181 ± 12 267 ± 23 0.75 ± 0.18 0.68 ± 0.22 0.50 ± 0.20 0.71 ± 0.15
p27Kip1+/+ diabetic (3 and 5 ) 180 ± 13 358 ± 25a 1.76 ± 0.16b 1.82 ± 0.19b 1.53 ± 0.15b 1.04 ± 0.12
p27Kip1+/− controls (2 and 2 ) 221 ± 14 291 ± 18 1.13 ± 0.33 0.89 ± 0.25 0.93 ± 0.24 0.49 ± 0.12
p27Kip1+/− diabetic (4 and 8 ) 204 ± 11 327 ± 21 1.56 ± 0.19 1.46 ± 0.22c 1.05 ± 0.27 1.07 ± 0.14
p27Kip1−/− controls (2 and 3 ) 177 ± 14 246 ± 17 1.46 ± 0.06a 1.30 ± 0.08a 1.33 ± 0.09b 0.49 ± 0.04
p27Kip1−/− diabetic (5 and 7 ) 217 ± 12a 312 ± 18 1.42 ± 0.18 1.00 ± 0.16d 0.97 ± 0.14d 0.87 ± 0.16
Abbreviations are: , female; , male animals.
aP < 0.05 versus controls +/+; bP < 0.01 versus controls +/+, cP < 0.05 versus controls +/−; dP < 0.05 versus diabetes +/+.
Fig. 1. Overview of morphologic findings
(low magnification). (A) p27Kip1+/+ control.
(B) p27Kip1+/− control. (C) p27Kip1−/− con-
trol. (D) p27Kip1+/+ diabetic. (E) p27Kip1+/−
diabetic. (F) p27Kip1−/− diabetic. Whereas
diabetic p27Kip1+/+ mice revealed glomeru-
losclerosis, tubulointerstitial, and vascular
damage (D) in contrast to nondiabetic
p27Kip1+/+ controls (A), kidneys of dia-
betic p27Kip1−/− mice (F) exhibited signifi-
cantly less morphologic changes of diabetic
nephropathy. Kidneys of diabetic p27Kip1+/−
animals (E) had an intermediated phenotype
[paraffin sections, periodic acid-Schiff (PAS),
magnification ×100].
Table 3. Glomerular cells
Mean Mesangial Mean Endothelial Mean endothelial
Total cell Podocyte podocyte cell mesangial cell cell endothelial cell
number/ number/ volume number/ volume number/ volume
glomerulus glomerulus lm3 glomerulus lm3 glomerulus lm3
p27Kip1+/+ controls (3 and 4 ) 237 ± 10 67 ± 3 331 ± 24 47 ± 3 369 ± 20 83 ± 7 120 ± 22
p27Kip1+/+ diabetic (3 and 5 ) 162 ± 16b 89 ± 11 407 ± 38 9 ± 2a 736 ± 16a 47 ± 5b 272 ± 40b
p27Kip1+/− controls (2 and 2 ) 166 ± 10 77 ± 4 359 ± 24 12 ± 2 476 ± 14 65 ± 4 146 ± 10
p27Kip1+/− diabetic (4 and 8 ) 158 ± 8 88 ± 3 386 ± 21 8 ± 1 472 ± 11 39 ± 4c 215 ± 30
p27Kip1−/− controls (2 and 3 ) 232 ± 8 78 ± 5 336 ± 27 40 ± 3 232 ± 21a 67 ± 4 157 ± 23
p27Kip1−/− diabetic (5 and 7 ) 170 ± 5 79 ± 3 354 ± 26 13 ± 2 650 ± 13 68 ± 3 120 ± 31
Abbreviations are: , female; , male animals.
aP < 0.05 versus controls +/+; bP < 0.01 versus controls +/+; cP < 0.05 versus controls +/−.
(Table 2). Diabetic p27Kip1+/− animals showed intermedi-
ate scores (Table 2). Mesangiolysis was not significant dif-
ferent among all groups (Table 2). Taken together, these
results support the notion that p27Kip1 is a critical deter-
minant of renal injury in diabetic nephropathy.
The quantitative morphometric analysis of glomeru-
lar cells on semithin sections is summarized in Table 3
and examples are provided in Figure 2. Mesangial
and endothelial cell numbers were reduced in diabetic
p27Kip1+/+ mice compared with controls. Mesangial cell
volume was increased in diabetic p27Kip1+/+ mice, indi-
cating cell hypertrophy and arrest in the G1 phase of the
cell cycle. These changes were significantly attenuated
in diabetic p27Kip1+/− and p27Kip1−/− animals. Although
podocyte number and volume were slightly increased in
diabetic p27Kip1+/+ but not in p27Kip1+/− and p27Kip1−/−
mice, the changes were not statistically significant
(Table 3).
There was no statistically significant difference in
length density of capillaries (i.e., the total capillary length
per glomerular volume) and mean and total surface of the
capillary tuft in all groups (Table 4).
Immunohistochemistry
Extracellular matrix synthesis and deposition is a hall-
mark of diabetic nephropathy. Therefore, we studied
renal expression of laminin and collagen type IV by
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Fig. 2. Examples of glomerular findings
(high magnification). (A) p27Kip1 +/+ control.
(B) p27Kip1+/− control. (C) p27Kip1−/− con-
trol. (D) p27Kip1+/+ diabetic. (E) p27Kip1+/−
diabetic. (F) p27Kip1−/− diabetic. Glomerular
hypertrophy in diabetic p27Kip1 +/+ animals
(D) is attenuated in diabetic p27Kip1+/− (E)
and p27Kip1−/− (F) genotypes (s emithin sec-
tions, methyline blue/basic fuchsine, magnifi-
cation ×250).
Table 4. Length density of glomerular capillaries (LV), mean glomerular convoluted surface (Akonm), total glomerular convoluted surface
(Akont)
LV mm/mm3 Akont ×10−3 mm2 Akonm ×10−3 mm2
p27Kip1+/+ controls (3 and 4 ) 12,974 ± 585 52.3 ± 1.3 2.3 ± 0.3
p27Kip1+/+ diabetic (3 and 5 ) 12,320 ± 707 53.0 ± 3.0 2.7 ± 0.1
p27Kip1+/− controls (2 and 2 ) 11,685 ± 829 37.3 ± 1.4 1.9 ± 0.1
p27Kip1+/− diabetic (4 and 8 ) 11,569 ± 422 50.8 ± 1.3 2.5 ± 0.1
p27Kip1−/− controls (2 and 3 ) 13,638 ± 1090 50.0 ± 4.4 2.5 ± 0.2
p27Kip1−/− diabetic (5 and 7 ) 13,014 ± 811 41.2 ± 2.2 2.1 ± 0.1a
Abbreviations are: , female; , male animals.
aP < 0.05 versus diabetes +/+.
Fig. 3. Immunohistochemical stainings. (A
to C) Type IV collagen. (D to F) Laminin. (G
to H) Transforming growth factor-b1 (TGF-
b1). Kidneys from p27Kip1+/+ nondiabetic
controls revealed only marginal stainings (A,
D, and G), whereas the expression of type IV
collagen (B), laminin (E), and TGF-b1 (H)
is strongly up-regulated in kidneys harvested
from diabetic p27Kip1+/+ mice. Expression of
type IV collagen (C) and laminin (F) was sig-
nificantly attenuated in diabetic p27Kip1−/−
kidneys compared to diabetic wild-type ani-
mals. In contrast, staining for TGF-b1 was not
decreased in diabetic p27Kip1−/− kidneys (I)
(magnification ×100).
immunohistochemistry. As shown in Figure 3A and B and
D and E, collagen type IV as well as laminin expression
was significantly increased in diabetic p27Kip1+/+ mice
(Fig. 3B and E) compared with nondiabetic p27Kip1+/+
controls (Fig. 3A and D). There was significantly less col-
lagen type IV and laminin staining in diabetic p27Kip1−/−
animals compared with the respective diabetic p27Kip1+/+
wild-types (Fig. 3C and F). TGF-b1 protein expression
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increased in diabetic p27Kip1+/+ mice compared with non-
diabetic wild-types (Fig. 3G and H). However, expression
of TGF-b 1 was not significantly attenuated in diabetic
p27Kip1−/− animals (Fig. 3I).
DISCUSSION
The present study demonstrates that deletion of the
p27Kip1 gene in mice attenuates the functional and
structural changes in diabetic nephropathy compared
to wild-type animals despite a comparable degree of
hyperglycemia. Diabetic heterozygous p27Kip1+/− mice
exhibited an intermediate phenotype. Therefore, p27Kip1
is crucial for the development of diabetic nephropathy
in mice. Morphometric analysis suggested that deletion
of the p27Kip1 gene attenuates diabetic glomerular hyper-
trophy, particularly of mesangial cells.
Awazu et al [10] recently reported that the lack of
p27Kip1 ameliorates the progression of diabetic nephropa-
thy in mice. In contrast to the current study that focused
on earlier time points, Awazu et al studied p27Kip1+/+ and
p27Kip1−/− mice 12 weeks after induction of diabetes by
STZ. They found reduced mesangial expansion in dia-
betic p27Kip1−/− animals compared with p27Kip1+/+ mice
12 weeks after induction of diabetes. Diabetic p27Kip1−/−
animals also had less albuminuria and renal fibronectin
protein expression compared to diabetic p27Kip1+/+ mice
[10]. Interestingly, renal TGF-b1 expression, induced
by diabetes, was not different between p27Kip1+/+ and
p27Kip1−/− mice [10], similar to findings in the current
study. However, Awazu et al did not investigate quantita-
tive glomerular, tubulointerstitial, and vascular damage
indices. In addition, quantitative analysis of glomerular
cells was not performed and heterozygous animals were
not studied. Therefore, we believe that our study confirms
and extends the findings of Awazu et al.
The key question is why does deletion of p27Kip1
attenuates diabetic nephropathy? We have previously
shown that p27Kip1 is necessary for hypertrophy in cul-
tured mesangial cells exposed to high glucose concentra-
tions [9]. This effect was caused by p27Kip1-mediated cell
cycle arrest facilitating enlargement of mesangial cells
[9]. Along this line Awazu et al [10] found that kidney
weight per body weight was lower in diabetic p27Kip1−/−
mice compared to diabetic wild-types. Indeed, our data
also confirmed that kidney weight per body weight was
lower in diabetic p27Kip1−/− mice compared with dia-
betic p27Kip1+/+ animals. However, the differences were,
at best, modest. Kidney weight is also not a sensitive mea-
sure of hypertrophy because it does not differentiate be-
tween an increase in total cell number or individually cell
mass [4]. However, quantitative analysis of glomerular
cells revealed that diabetes induces an increase in vol-
umes of mesangial and endothelial cells in p27Kip1 wild-
type mice with a concomitant reduction in cell number.
These results are consistent with hypertrophy caused by
G1 phase arrest [8]. In contrast, deletion of one p27Kip1
allele reduced hypertrophy in diabetic, but not in con-
trol animals. Thus, part of the protective effect in p27Kip1
gene deletion could be contributed to the reduced hyper-
trophy, principally confirming our in vitro data.
However, we believe that additional mechanisms may
explain how the complete or partial deletion of p27Kip1
expression ameliorates the functional and structural ab-
normalities of diabetic nephropathy. There is increasing
evidence that cyclin-dependent kinase inhibitor such as
p21Waf1/Cip1 and p27Kip1 have functions beyond the reg-
ulation of the cell cycle [18–20]. For example, Fan and
Weiss [18] inhibited p21Waf1/Cip1 expression with phos-
phorothioate antisense oligonucleotides in rat mesangial
cells exposed to high glucose. Not unexpectantly, high
glucose-mediated mesangial cell hypertrophy was atten-
uated in cells with inhibition of p21Waf1/Cip1 expression
by the antisense approach [18]. Surprisingly, cell prolif-
eration was not increased in this setting but was further
reduced compared with control cells exposed to high glu-
cose alone [18]. These data suggest a dissociation be-
tween p21Waf1/Cip1 effects on hypertrophy and cell cycle
regulation. Using mesangial cells from double-knockout
p21Waf1/Cip1 and p27Kip1 mice, we recently found that
these cyclin-dependent kinase inhibitors are not required
for the antiproliferative effects of TGF-b [19]. However,
the hypertrophic growth effects of TGF-b were reduced
in the absence of both p21Waf1/Cip1 and p27Kip1 [19]. This
suggests that hypertrophy induced by TGF-b is not sec-
ondary to antiproliferation and that there is a mechanism
of hypertrophy independent of cell cycle arrest and de-
pendent on p21Waf1/Cip1 and p27Kip1 [20].
In a recent study, Besson et al [21] reported that p27Kip1
modulates cell migration. p27Kip1−/− fibroblasts exhibited
a dramatic decrease in mobility compared with wild-type
cells [22]. p27Kip1 interacts via its C- terminus with RhoA
and reduces activation of the RhoA pathway [23]. As a
consequence, in the absence of p27Kip1 the Rho pathway
is stimulated leading to an increased formation of stress
fibers and focal adhesions that can lead to an inhibition
of cell migration by increasing cellular adhesion to its
substrate and preventing focal adhesion turnover [23].
Recently, a novel mechanism in which mature tubular
epithelial cells undergo epithelial-to-mesenchymal tran-
sition (EMT) has been described [24]. It is assumed that
EMT plays a pivotal role in the development of fibro-
sis in various primary renal diseases, including diabetic
nephropathy [25]. However, enhanced cell migration is
a key feature of EMT in which former epithelial cells
acquire properties of fibroblasts and migrate after dis-
ruption of the tubular basement membrane into the in-
terstitium where they increase synthesis of extracellular
matrix proteins [26]. It is intriguing to speculate that dis-
ruption of the p27Kip1 gene would lead to less migration
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of transformed epithelial cells because they adhere to
remnants of the tubular basement membrane through
Rho-activated stress fibers.
Our study indicates that deletion of one p27Kip1 allele
is already partly protective suggesting haplotype insuffi-
ciency. These findings are in agreement with observations
of Fero et al [27] demonstrating that p27Kip1+/− heterozy-
gous mice are predisposed to tumors in multiple tissues
when challenged with carcinogens or c radiation. There-
fore, p27Kip1 does not fulfill the two-mutation criterion
as first postulated by Knudson [28]. Furthermore, ther-
apeutic reduction of p27Kip1 expression being beneficial
for the development of diabetic nephropathy may cause
an increased risk in developing tumors.
It seems reasonable to conclude from our study that
modulating p27Kip1 expression could attenuate the de-
velopment of diabetic nephropathy.
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